Markman on Oncology
Maurie Markman, MD, is currently president of medicine and science at Cancer Treatment Centers of America in Philadelphia. He has more than 20 years of experience in cancer treatment and gynecologic oncology research, and most recently served as vice president for clinical research and chairman of the Department of Gynecologic Medical Oncology at MD Anderson Cancer Center in Houston, Texas. In June 2011, he received the ASCO Statesman Award.
+ Add to Email Alerts
+ Add to Email Alerts
- Immunotherapy Toxicity: How Much Do Physicians Know?
- Cancer Statistics: Public Health Improvements and Future Thoughts
- Advanced Ovarian Cancer: 20% Disease-Free Survival at 10 Years
- Is Trametinib a New Standard for Low-Grade Serous Ovarian Cancer?
- Behavioral Modification Could Prevent Nearly 50% of Cancer Deaths
- Bariatric Surgery Reduces Obesity-Related Cancer Risk
- SOLO1: 7-Year Follow-up Highlights the Value of Maintenance Olaparib
- Reassuring Data: Olaparib Dose Reductions Have Minimal Effect
- Ovarian Cancer Is Not Silent: Common, Nonspecific Symptoms
- Synergy With Combo Checkpoint Inhibitors: Fact or Fiction?
- Single-Dose HPV Vaccination Strategy May Be Coming
- Gynecologic Cancer Studies: What to Look for at ASCO 2022
- Young Adult Obesity Has Quintupled. Will 'Cancer Wave' Follow?
- Cancer Data Reproducibility Problem Undermines Public Trust
- Physical Activity Reduces Cognitive Decline in Breast Cancer
- The Impact of HPV Vaccination on Cervical Cancer
- ASCO 2021 ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer
- 'High-Speed' Science: It's Time We Slow Down
- Ovarian Cancer Trials: The Good News and the Bad News
- New Options for Rare Cancer Mutations: Basket and 'Just-in-Time' Trials